triphenyl phosphate has been researched along with rosiglitazone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, BC; Emili, A; Farmer, S; Hekman, R; Kim, S; Rabhi, N; Schlezinger, JJ; Wynne, K | 1 |
1 other study(ies) available for triphenyl phosphate and rosiglitazone
| Article | Year |
|---|---|
Triphenyl phosphate is a selective PPARĪ³ modulator that does not induce brite adipogenesis in vitro and in vivo.
Topics: 3T3-L1 Cells; Adipocytes; Adipocytes, Beige; Adipogenesis; Adipose Tissue; Animals; Cell Differentiation; Mice; Organophosphates; PPAR gamma; Rosiglitazone; Toxicity Tests | 2020 |